Article
Immunosenescence in multiple sclerosis: the identification of new therapeutic targets
5 Jul 2021
Abstract excerpt
The number of elderly multiple sclerosis (MS) patients is growing, mainly due to the increase in the life expectancy of the general population and the availability of effective disease-modifying treatments. However, current treatments reduce the frequency of relapses and slow the progression of the disease, but they cannot stop the disability accumulation associated with disease progression. One possible...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
